Nutrien Ltd.

Informe acción TSX:NTR

Capitalización de mercado: CA$47.3b

Nutrien Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Los beneficios de Nutrien han disminuido a una tasa media anual de -19.2%, mientras que en la industria Chemicals los beneficios crecieron en un 12.4% anualmente. Los ingresos han ido disminuyendo a una tasa media de 1.4% al año. La rentabilidad financiera de Nutrien es de 9.6%, y sus márgenes netos son de 8.9%.

Información clave

-19.25%

Tasa de crecimiento de los beneficios

-16.39%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 4.55%
Tasa de crecimiento de los ingresos-1.38%
Rentabilidad financiera9.59%
Margen neto8.88%
Próxima actualización de resultados06 Aug 2026

Actualizaciones de resultados anteriores recientes

Recent updates

Actualización de narrativa May 03

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns

The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Actualización de narrativa Apr 19

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.
Actualización de narrativa Apr 04

NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns

Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.
Actualización de narrativa Mar 21

NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance

Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.
Actualización de narrativa Mar 07

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.
Actualización de narrativa Feb 21

NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns

Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.
Actualización de narrativa Feb 07

NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Actualización de narrativa Jan 23

NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside

Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.
Actualización de narrativa Jan 09

NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks

Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.
Actualización de narrativa Dec 21

NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing

Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.
Actualización de narrativa Dec 07

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.
Actualización de narrativa Nov 23

NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead

Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.
Actualización de narrativa Nov 07

NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny

Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.
Actualización de narrativa Oct 24

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty

Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.
Actualización de narrativa Oct 09

Global Food Demand And Precision Ag Will Secure Fertilizer Success

Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.
Artículo de análisis Sep 08

With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...
Artículo de análisis Aug 08

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...
Artículo de análisis Jul 16

Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Artículo de análisis Jul 03

A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
User avatar
Nueva narrativa Feb 09

Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations

Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.

Desglose de ingresos y gastos

Cómo gana y gasta dinero Nutrien. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

TSX:NTR Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 2626,8772,3874,2150
31 Dec 2525,9492,2674,0870
30 Sep 2525,6711,8094,0800
30 Jun 2525,0211,3634,0900
31 Mar 2524,7395274,1180
31 Dec 2425,0166744,1210
30 Sep 2425,5567334,2070
30 Jun 2425,8397904,2220
31 Mar 2427,3258454,1180
31 Dec 2328,0821,2584,0940
30 Sep 2329,9672,1983,9490
30 Jun 2332,5833,7003,9590
31 Mar 2335,4666,8533,9920
31 Dec 2237,0127,6604,0500
30 Sep 2236,7927,7494,1800
30 Jun 2234,6126,8894,1010
31 Mar 2229,8684,4044,0150
31 Dec 2126,8613,1533,8260
30 Sep 2123,6422,2683,6630
30 Jun 2121,8619643,5520
31 Mar 2120,5146213,4090
31 Dec 2020,0534593,3240
30 Sep 2019,534953,2130
30 Jun 2019,4708233,0840
31 Mar 2019,7549163,0520
31 Dec 1919,3169923,0280
30 Sep 1919,6711,3362,8890
30 Jun 1919,4491282,9290
31 Mar 1918,862112,9300
31 Dec 1818,772-312,8910
30 Sep 1816,051-4472,2980
30 Jun 1813,3766361,6310
31 Mar 186,489478290
31 Dec 174,0101542330
30 Sep 173,9731962180
30 Jun 173,8932612210
31 Mar 173,8242302330
31 Dec 163,9211992310
30 Sep 164,2394782530
30 Jun 164,6586792460
31 Mar 165,3309752510
31 Dec 155,7911,1152580
30 Sep 156,3031,4762580
30 Jun 156,4021,5112550

Ingresos de calidad: NTR tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (8.9%) de NTR son superiores a los del año pasado (2.1%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de NTR han disminuido en un 19.2% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de NTR en el último año (352.9%) supera su media de 5 años (-19.2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de NTR en el último año (352.9%) superó al de la industria Chemicals 0.1%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de NTR (9.6%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/20 01:07
Precio de las acciones al final del día2026/05/20 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Nutrien Ltd. está cubierta por 52 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays